Published in Br J Dermatol on November 01, 1975
Hypocomplementemia in keratoacanthoma. Arch Dermatol Res (1981) 0.75
Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol (1991) 3.29
Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol (1983) 1.98
Experimental production of antibodies against stratum corneum keratin polypeptides. Arch Dermatol Res (1980) 1.87
Attempt to protect rabbits against experimental syphilis by passive immunization. Br J Vener Dis (1973) 1.68
Porokeratosis and immunosuppression. Eur J Dermatol (1999) 1.62
Milia-like idiopathic calcinosis cutis. Pediatr Dermatol (2004) 1.57
Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases. Ann Rheum Dis (1985) 1.54
External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment. Arch Dermatol (1997) 1.53
Antinuclear autoantibodies in Swiss mice thymectomized at birth. Nature (1967) 1.50
PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. J Invest Dermatol (1980) 1.46
[Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid]. Ann Dermatol Venereol (1999) 1.39
Clinical picture: eyelid metastasis. Lancet (2001) 1.39
[Oral photochemotherapy in vitiligo (author's transl)]. Ann Dermatol Venereol (1979) 1.39
Immunohistochemical study of CD34-positive dendritic cells of human dermis. Am J Dermatopathol (1996) 1.25
Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang (1971) 1.23
Keratin polypeptides distribution in normal and diseased human epidermis and oral mucosa. Immunohistochemical study on unaltered epithelium and inflammatory, premalignant and malignant lesions. Virchows Arch A Pathol Anat Histol (1980) 1.18
Investigation of a specific IgM antibody test in neonatal congenital syphilis. Br J Vener Dis (1970) 1.14
Lectins as markers of human epidermal cell differentiation. Differentiation (1982) 1.12
Specific immunity in patients suffering from recurring warts before and after repetitive intradermal tests with human papilloma virus. Br J Dermatol (1977) 1.11
[Immunofluorescence studies of serum autoantibodies with respect to the constituents of the epidermis of burned patients]. Experientia (1968) 1.09
Interleukin-6 in normal skin and psoriasis. Acta Derm Venereol (1992) 1.09
Progressive replacement of human cultured epithelial allografts by recipient cells as evidenced by HLA class I antigens expression. Dermatologica (1987) 1.08
Congenital self-healing histiocytosis (Hashimoto-Pritzker). An ultrastructural and immunohistochemical study. Cancer (1988) 1.07
The atrophic variant of dermatofibrosarcoma protuberans in childhood: a report of six cases. Br J Dermatol (1998) 1.06
Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. J Invest Dermatol (1983) 1.06
Precocious appearance of involucrin and epidermal transglutaminase during differentiation of psoriatic skin. Br J Dermatol (1986) 1.05
Expression of the CD34 antigen distinguishes Kaposi's sarcoma from pseudo-Kaposi's sarcoma (acroangiodermatitis). Br J Dermatol (1996) 1.04
[Scleroderma en coup de sabre with homolateral chronic glaucoma (author's transl)]. Ann Dermatol Venereol (1977) 1.00
Oral photochemotherapy in the treatment of lichen planus (LP). Clinical results, histological and ultrastructural observations. Br J Dermatol (1978) 1.00
Immunocytochemical evidence for a possible role of cross-linked keratinocyte envelopes in stratum corneum cohesion. J Histochem Cytochem (1991) 1.00
PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study. Br J Dermatol (1979) 0.99
Expression of the hair stem cell-specific keratin 15 in pilar tumors of the skin. Eur J Dermatol (1999) 0.99
[Australia antigen, virus hepatitis and periarteritis nodosa]. Presse Med (1970) 0.99
Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol (1995) 0.98
Differential expression of the CD10 antigen (neutral endopeptidase) in primary versus metastatic malignant melanomas of the skin. Melanoma Res (2002) 0.98
Morphological, immunological and immunocytochemical identification of lymphocytes extracted from cutaneous infiltrates. Clin Exp Immunol (1976) 0.97
[Maternally-transmitted severe neonatal aphthosis]. Ann Dermatol Venereol (1982) 0.97
Normal and psoriatic human skin grafts on "nude" mice: morphological and immunochemical studies. J Invest Dermatol (1981) 0.97
Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol (1990) 0.96
CD4 antibody treatment of severe psoriasis. Lancet (1991) 0.96
Anti-D47: a monoclonal antibody reacting with the secretory cells of human eccrine sweat glands. Br J Dermatol (1983) 0.96
Squamous cell carcinoma of the skin complicating lupus vulgaris. J Eur Acad Dermatol Venereol (2006) 0.96
Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol (1992) 0.96
Lichen planus and chronic graft-versus-host reaction. In situ identification of immunocompetent cell phenotypes. J Cutan Pathol (1982) 0.96
In vitro mixed skin cell lymphocyte culture reaction (MSLR) in man: analysis of the epidermal cell and T cell subpopulations. Clin Exp Immunol (1982) 0.96
Expression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes. Arch Dermatol Res (1997) 0.96
Anti-CD4 monoclonal antibody therapy in severe psoriasis. J Autoimmun (1992) 0.95
Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial. Br J Dermatol (2001) 0.95
[Contribution to the study of the treponeme isolated from monkeys by A. Fribourg-Blanc]. Bull World Health Organ (1969) 0.94
Immunohistochemical study of normal skin of HIV-1-infected patients shows no evidence of infection of epidermal Langerhans cells by HIV. AIDS Res Hum Retroviruses (1989) 0.94
Bullous dermatosis and myeloma. Monoclonal anticytoplasmic antibody activity. Arch Dermatol (1980) 0.94
Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells. Br J Dermatol (1983) 0.93
[Significance of anti-mitochondria antibodies in liver pathology and during syphilis]. Pathol Biol (Paris) (1973) 0.93
Quantitative evaluation of two distinct cell populations expressing HLA-DR antigens in normal human epidermis. Br J Dermatol (1984) 0.93
[The electron of antibodies fixed in vivo the skin level in pemphigus, bullous pemphigoid and lupus erythematosus]. Lyon Med (1972) 0.93
Keratin polypeptide modifications induced by human papilloma viruses (HPV). Arch Dermatol Res (1981) 0.93
Australia antigen and polyarteritis nodosa. Am J Dis Child (1972) 0.93
Comparative study of delayed hypersensitivity skin reactions and antibodies to human papilloma virus (HPV). Clin Exp Immunol (1977) 0.93
Expression of an estrogen receptor-associated protein (p29) in epithelial tumors of the skin. J Cutan Pathol (1989) 0.93
Detection of human immunodeficiency virus-DNA and RNA in the skin of HIV-infected patients using the polymerase chain reaction. J Invest Dermatol (1991) 0.92
[Leucocytoclastic vasculitis and sarcoidosis. Apropos of a case]. Ann Dermatol Venereol (1980) 0.92
Sequence of changes in psoriatic epidermis. Immunocompetent cell redistribution precedes altered expression of keratinocyte differentiation markers. Acta Derm Venereol (1988) 0.92
Cytokeratins in human basal and squamous cell carcinomas: biochemical, immunohistological findings and comparisons with normal epithelia. J Cutan Pathol (1982) 0.91
Long-term survival and immunological tolerance of human epidermal allografts produced in culture. Transplantation (1986) 0.91
Skin diseases in children with organ transplants. J Am Acad Dermatol (2001) 0.90
[SWAN mice. (Swiss antinuclear). Animal models for the study of acute, disseminated lupus erythematosus and amyloidosis. Immunopathological study]. Pathol Eur (1971) 0.90
Multiple eruptive dermatofibromas in a patient with HIV infection: case report and literature review. J Cutan Pathol (2000) 0.90
Langerhans cells in human warts. Br J Dermatol (1986) 0.90
Involucrin expression in keratinization disorders of the skin--a preliminary study. Br J Dermatol (1987) 0.90
Impairement of thymus derived rosette forming cells during photochemotherapy (psoralen--U.V.A.). Arch Dermatol Res (1978) 0.90
Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in man. Cell Immunol (1984) 0.90
Studies on T-cell subsets in atopic dermatitis: human T-cell subpopulations defined by specific monoclonal antibodies. Clin Immunol Immunopathol (1982) 0.89
A sequential study of histological and immunological changes in the skin after allogenic bone marrow transplantation. Transplantation (1986) 0.89
[Erythema giratum repens in myelosarcoma]. Bull Soc Fr Dermatol Syphiligr (1970) 0.89
Primary localized gigantism and tuberous sclerosis. Arch Dermatol (1982) 0.89
Flow cytometry for separation of keratinocyte subpopulations from the viable epidermis. J Invest Dermatol (1986) 0.88
Disseminated superficial porokeratosis in a patient with AIDS. Br J Dermatol (1994) 0.88
A new way to evaluate the germinative compartment in human epidermis, using [3H]thymidine incorporation and immunoperoxidase staining of 67 K polypeptide. Br J Dermatol (1983) 0.88
Identification of specific human epithelial cell integrin receptors as VLA proteins. Exp Cell Res (1990) 0.88
Role of thiol compounds in mammalian melanin pigmentation: Part I. Reduced and oxidized glutathione. J Invest Dermatol (1981) 0.88
HLA class I antigen (heavy and light chain) expression by Langerhans cells and keratinocytes of the normal human epidermis: ultrastructural quantitation using immunogold labelling procedure. Arch Dermatol Res (1988) 0.88
[Migrating cutaneous erythema with superficial epidermal necrosis in the course of chronic pancreatitis]. Ann Dermatol Syphiligr (Paris) (1974) 0.88
Detection of OKT6-positive cells (without visible Birbeck granules) in normal peripheral blood. Immunol Lett (1984) 0.88
Cyclosporine. An immunosuppressant affecting epithelial cell proliferation. Arch Dermatol (1990) 0.87
Infection of human epidermal Langerhans' cells by HIV. AIDS (1990) 0.87
A longitudinal study of a harlequin infant presenting clinically as non-bullous congenital ichthyosiform erythroderma. Br J Dermatol (1996) 0.87
Topical retinoids for warts and keratoses in transplant recipients. Lancet (1992) 0.87
Interleukin-1 beta stimulates fibroblast elastase activity. Br J Dermatol (1991) 0.87
Lichen planus: evaluation of cells in skin lesions and of T-lymphocyte subsets in blood. J Dermatol (1983) 0.87
[Anti-epidermal antibodies in bullous dermatoses. Clinical and experimental data]. Bull Soc Fr Dermatol Syphiligr (1967) 0.87
[Pemphigus and thymoma: review and etiopathogenesis (author's transl)]. Ann Dermatol Venereol (1981) 0.86
Cultured human epidermal allografts are not rejected for a long period. Arch Dermatol Res (1986) 0.86
An in vivo study of cell-mediated immunity in human warts. Preliminary results. Acta Derm Venereol (1977) 0.86
Filaggrin expression in normal and pathological skin. A marker of keratinocyte differentiation. Virchows Arch A Pathol Anat Histopathol (1988) 0.86
Thomsen-Friedenreich and its precursor (Tn) antigen expression in normal skin and in benign cutaneous tumours: a marker for sebaceous differentiation. Acta Derm Venereol (1998) 0.86